⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Alzheimer's Disease Competitive Landscape and Clinical Trial Analysis Report 2026: More Than 200 Companies and 240 Therapies Assessed
globenewswire.com
LLY
BIIB
JNJ
SNY
ALNY
ABBV
BMY
REGN
XCUR
Global Lupus Nephritis Market to Reach USD 4.08 Billion by 2034 at 8.5% CAGR as Rising Disease Burden and Breakthroughs in Targeted Therapies Accelerate Market Expansion, Says Maximize Market Research
prnewswire.com
PFE
AZN
MRK
BMY
GSK
AMGN
BIIB
JNJ
VRTX
IMVT
ABBV
LLY
SNY
REGN
GILD
BHC
AUR
UCB
Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach
prnewswire.com
ABBV
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
prnewswire.com
ABBV
Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight
globenewswire.com
ABBV
AMGN
JNJ
TAK
UCB
MRK
PFE
GILD
LLY
NVS
AZN
BHC
AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery
prnewswire.com
ABBV
Highlights to be presented at Novo’s Capital Markets Day 2026
globenewswire.com
NVO
LLY
AZN
GILD
JNJ
ABBV
NVS
SAN
ROG
GSK
AMGN
MRK
REGN
PFE
BMY
Ozi Amanat, Backer of Neuralink, SpaceX, xAI, Shield AI, Lambda, and Tenstorrent, Expands K2 Global’s Frontier Technology Investments
globenewswire.com
TSLA
NXPI
NVDA
AMD
INTC
MU
GOOGL
MSFT
AMZN
IBM
META
SPCE
UPST
PLTR
UBER
SPOT
ABNB
PYPL
COIN
CRSP
EDIT
BEAM
MRNA
BNTX
GILD
BMY
LLY
JNJ
PFE
ABBV
REGN
BIIB
AZN
XOM
CVX
SHEL
TTE
COP
EOG
APA
OXY
VLO
MPC
PSX
JPM
BAC
WFC
C
GS
MS
SCHW
AXP
V
MA
ADBE
CRM
ORCL
SAP
HPQ
DELL
HPE
CSCO
QCOM
AVGO
AMAT
LRCX
KLAC
ASML
ON
ADI
TXN
MCHP
SNPS
CDNS
MRVL
ALGN
ISRG
ROST
ULTA
TJX
MDT
SYK
BA
GD
LMT
RTX
BAX
DHR
ETSY
MELI
JD
BABA
PDD
NTES
IQ
BIDU
GOOG
AAPL
ACN
T
VZ
CHTR
CMCSA
NFLX
DIS
WBD
PARA
FOXA
FOX
CMG
MCD
SBUX
YUM
QSR
SIRI
AMC
NCLH
CCL
RCL
LVS
WYNN
MGM
EA
TTWO
BILI
AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026
prnewswire.com
ABBV
Velocity Clinical Research appoints Justin Starzyk as Chief Executive Officer
globenewswire.com
ABBV